Cannabinoid Clinical Trials: PTSD and Substance Use
Cannabinoid clinical trials PTSD substance use reveal that cannabis does not reduce the effectiveness of trauma-focused treatments. People with PTSD and substance use disorders benefit from evidence-based therapies despite cannabis use. These trials…
`Cannabinoid Clinical Trials: Cannabis, PTSD & Substance Use`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments. Cannabis use should not be used as a reason to withhold or delay evidence-based PTSD care in this…
Cannabinoid Clinical Trials: PTSD and Substance Use Meta-Analysis
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments. Cannabis use does not appear to prevent evidence-based PTSD therapies from working, which supports…
`Cannabinoid Clinical Trials: Cannabis, PTSD and Substance Use`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who also use cannabis can still benefit meaningfully from trauma-focused treatments. Clinicians should not withhold or delay evidence-based PTSD care based on a patient’s…
Endocannabinoid System & Teen Anxiety: Clinical Evidence
Internalising symptoms adolescent cannabis use is linked to increased risk of initiation and escalation among teens. This clinical evidence highlights the importance of screening for anxiety and depression in adolescents. Understanding these risks can…